Standardised guidance for the the investigatio... - CLL Support
Standardised guidance for the the investigation and management of CLL in Australia and NZ
You need to be a member of this community to see this post.
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Managing the cardiovascular risk of Bruton's Tyrosine Kinase Inhibitors in chronic lymphocytic leukemia
The American Society of Hematology journal Blood Advances published an important...
Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience
This is the full report from ASH Publications Blood Journam yesterday by Dr Mayo et al....
BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'
In just a short time, in many places, BTK inhibitors (BTKi) have largely replaced...
Living in the USA with CLL and want to know where to sign up for your COVID-19 Vaccination? A State-by-State List
From MedPage Today: Every state has posted information on its plan; many (though not all) list...
Ibrutinib-Venetoclax is the recommended first-line therapy for fit Arab patients with CLL in the Gulf region
A group of CLL experts from across the Gulf region and an international expert from Germany have...
Related Posts
COVID-19 management strategies and vaccine recommendations for patients with hematologic malignancies, USA NY Presbyterian perspective- Autoimmune hemolytic anemia (AIHA), Immune thrombocytopenia (ITP) and other autoimmune complications and extranodal involvement in CLL
- Important SARS-CoV-2 and Covid-19 information for Chronic Lymphocytic Leukaemia/CLL patients
- Consensus recommendations for CLL/SLL treatment selection and sequencing in the US
- Research shows blood cancer patients generate strong T cell immunity after SARS-CoV-2 vaccination
